Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization

• Váldodahkkit: Basanth Babu Eedara (Dahkki), Claire Fan (Dahkki), Shubhra Sinha (Dahkki), Prakash Khadka (Dahkki), Shyamal C. Das (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2023-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Tuberculosis (TB) is an infectious disease resulting in millions of deaths annually worldwide. TB treatment is challenging due to a huge number of global latent infections and due to multidrug-resistant forms of TB. Inhaled administration of anti-TB drugs using dry powder inhalers has various advant...